Mo Huang

4PUBLICATIONS
23CO-AUTHORS
Molecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 23, 2025
Intratumoral or Subcutaneous MK-2118, a Noncyclic Dinucleotide STING Agonist, with or without Pembrolizumab, for Advanced or Metastatic Solid Tumors or Lymphomas.

Jason J Luke, Randy F Sweis, J Randolph Hecht

|Oct 31, 2023
Statistical Interpretation and Comparison of Waterfall Plots.

Mo Huang, Cong Chen, Linda Z Sun

|Dec 31, 2021
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.

Gareth P Gregory, Shaji Kumar, Ding Wang

|Sep 01, 2019
Data denoising with transfer learning in single-cell transcriptomics.

Jingshu Wang, Divyansh Agarwal, Mo Huang

Pageof 1